日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Efficacy and safety of neoadjuvant treatment of trastuzumab and pyrotinib plus dalpiciclib in HR-negative/HER2-positive breast cancer: an exploratory, open-label phase II study

曲妥珠单抗和吡咯替尼联合达匹西利新辅助治疗HR阴性/HER2阳性乳腺癌的疗效和安全性：一项探索性、开放标签的II期研究

期刊:International Journal of Surgery
影响因子:10.1
doi:10.1097/JS9.0000000000003328
Xiao, Zhi; Chen, Feiyu; Liao, Liqiu; Luo, Shayang; Liu, Xuan; Liu, Xiangyan; Xu, Tao; Hu, Yu; Luo, Na; Wang, Wenlong; Cao, Jing; Wang, Kuansong; Zhou, Haiyan; Ding, Nianhua; Li, Yan; Huang, Juan; Wang, Shouman
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2026
文献求助 收藏

Single-cell transcriptome analysis reveals the malignant characteristics of tumour cells and the immunosuppressive landscape in HER2-positive inflammatory breast cancer.

单细胞转录组分析揭示了 HER2 阳性炎性乳腺癌中肿瘤细胞的恶性特征和免疫抑制图谱

期刊:Journal of Experimental & Clinical Cancer Research
影响因子:12.8
doi:10.1186/s13046-025-03454-z
Huang Juan, Zhu Yongwei, Zeng Wenjing, Zhang Yulong, Xia Weizhi, Xia Fan, Liu Liyu, Wang Kuansong, Guan Yidi, Shen Taohong, Jiang Bingjian, Sun Lunquan, Cao Ayong, Wang Shouman, Li Zhi
细胞生物学
肿瘤
乳腺癌
单细胞
发表日期：2025
文献求助 收藏

Eurochevalierines A - I, Sesquiterpene Alkaloid Hybrids with Anti-Triple Negative Breast Cancer Activity from Penicillium sp. HZ-5

Eurochevalierines A - I，来自青霉菌 HZ-5 的具有抗三阴性乳腺癌活性的倍半萜生物碱混合物

期刊:Journal of Agricultural and Food Chemistry
影响因子:5.7
doi:10.1021/acs.jafc.4c04011
Yeting Zhang, Qing Li, Jinlong Zhang, Ming Chen, Xuan Li, Yuben Qiao, Kuansong Wang, Changxing Qi, Yonghui Zhang
肿瘤
乳腺癌
发表日期：2024
文献求助 收藏

Preclinical and Basic Research Strategies for Overcoming Resistance to Targeted Therapies in HER2-Positive Breast Cancer

克服HER2阳性乳腺癌靶向治疗耐药性的临床前和基础研究策略

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers15092568
Cao, Yi; Li, Yunjin; Liu, Ruijie; Zhou, Jianhua; Wang, Kuansong
肿瘤
HER2
肿瘤免疫
治疗耐药
乳腺癌
发表日期：2023
文献求助 收藏

Treatment strategies for clear cell renal cell carcinoma: Past, present and future

透明细胞肾细胞癌的治疗策略：过去、现在和未来

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2023.1133832
Yang, Junwei; Wang, Kuansong; Yang, Zhichun
肿瘤
肾癌
肿瘤免疫
细胞生物学
发表日期：2023
文献求助 收藏

Neoadjuvant chemotherapy for breast cancer: an evaluation of its efficacy and research progress

乳腺癌新辅助化疗：疗效评价及研究进展

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2023.1169010
Chen, Yushi; Qi, Yu; Wang, Kuansong
肿瘤
肿瘤免疫
乳腺癌
发表日期：2023
文献求助 收藏

Incorporating ultrasound-based lymph node staging significantly improves the performance of a clinical nomogram for predicting preoperative axillary lymph node metastasis in breast cancer

将基于超声的淋巴结分期纳入临床列线图可显著提高乳腺癌术前腋窝淋巴结转移预测的性能。

期刊:Biomolecules Biomedicine
影响因子:2.2
doi:10.17305/bb.2022.8564
Wang, Xiaomin; Yi, Xiaoping; Zhang, Qian; Wang, Xiaoxiao; Zhang, Hanghao; Peng, Shuai; Wang, Kuansong; Liao, Liqiu
肿瘤
肿瘤免疫
乳腺癌
发表日期：2023
文献求助 收藏

Preparing Data for Artificial Intelligence in Pathology with Clinical-Grade Performance

为病理学人工智能准备临床级性能数据

期刊:Diagnostics
影响因子:
doi:10.3390/diagnostics13193115
Yang, Yuanqing; Sun, Kai; Gao, Yanhua; Wang, Kuansong; Yu, Gang
发表日期：2023
文献求助 收藏

eEF2K promotes PD-L1 stabilization through inactivating GSK3β in melanoma

eEF2K 通过抑制黑色素瘤中的 GSK3β 来促进 PD-L1 稳定

期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.3
doi:10.1136/jitc-2021-004026
Xisha Chen, Kuansong Wang, Shilong Jiang, Hongyin Sun, Xuanling Che, Minghui Zhang, Jiaying He, Ying Wen, Mengting Liao, Xiangling Li, Xiaoming Zhou, Jianxun Song, Xingcong Ren, Wenjun Yi, Jinming Yang, Xiang Chen, Mingzhu Yin, Yan Cheng
肿瘤
黑色素瘤
WB
发表日期：2022
文献求助 收藏

HER-2-positive primary neuroendocrine neoplasms of the breast with signet ring feature: A case report and review of literature

HER-2阳性乳腺原发性神经内分泌肿瘤伴印戒细胞特征：病例报告及文献复习

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2022.1029007
Li, Yunjin; Cao, Yi; Wu, Xiaoying; Liu, Ruijie; Wang, Kuansong
细胞生物学
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏